COMMUNIQUÉS West-GlobeNewswire

Merus to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
UTRECHT, The Netherlands, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton [...]
Spark Therapeutics to Participate in Multiple Conferences in January
02/01/2018
PHILADELPHIA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that Jeffrey D. [...]
Aptose Biosciences to Present at Biotech Showcase™ 2018 Conference
02/01/2018
SAN DIEGO and TORONTO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms [...]
Agios to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018
02/01/2018
CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is [...]
BioCorRx CEO, Brady Granier, Appears on Fox & Friends to Discuss the Opioid Epidemic
02/01/2018
ANAHEIM, CA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]
G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]
Apellis Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]
Melinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor Relations
02/01/2018
NEW HAVEN, Conn., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing, and commercializing novel antibiotics to treat serious bacterial [...]
NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development
02/01/2018
Series A financing co-led by ArrowMark Partners and Barer & Son Capital Financing supports initiation of Phase I/II trial of AIM TM ACT in relapsed/refractory Hematologic Malignancies in 2018 GAITHERSBURG, Md., Jan [...]
AnaptysBio Announces Presentation at the J.P. Morgan 36th Annual Healthcare Conference
02/01/2018
SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]
Transactions in relation to share buyback program
02/01/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
ContraVir Pharmaceuticals to Present at Biotech Showcase 2018
02/01/2018
EDISON, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Hepatocellular Carcinoma
02/01/2018
CAMBRIDGE, Mass. and BEIJING, China, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 December 2017)
02/01/2018
Bagsværd, Denmark, 2 January 2018 - In continuation of the company's announcements dated 9 August 2017 and 1 November 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York [...]
HealthLynked Corp. Announces release of its Medical Newsfeed Service for Members and Providers
02/01/2018
NAPLES, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced the release of its new design with the introduction of its newsfeed service. The new design allows members to access the [...]
Dr. Brian O’Connor Joins Veritas Pharma Advisory Board
02/01/2018
VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor, a consultant in [...]
How assessURhealth™ worked to #EndTheStigma in 2017
01/01/2018
Tampa, Jan. 01, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a leading provider of mental and behavioral health screening software, took their mission to new heights in 2017. Expanding their integration capabilities [...]
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017
31/12/2017
Company Release no. 27/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2017 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017 Veloxis Pharmaceuticals A/ [...]
Helius Medical Technologies Announces Closing of Final Tranche of Private Placement
30/12/2017
NEWTOWN, Pa., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, is [...]

Pages